Literature DB >> 26519209

Inherited Structural Heart Diseases With Potential Atrial Fibrillation Occurrence.

Roberta Manuguerra1, Sergio Callegari2, Domenico Corradi1.   

Abstract

Inherited cardiac diseases inducing structural remodeling of the myocardium sometimes develop arrhythmias of various kinds. Among these rhythm disturbances, atrial fibrillation is well known to frequently worsen the prognosis of the primary disorder by increasing morbidity and mortality, especially because of a higher rate of heart failure. In this manuscript, we have reviewed the literature on the most important inherited structural cardiac diseases in whose clinical history atrial fibrillation may occur fairly often.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  LV noncompaction; amyloidosis; atrial fibrillation; genetics; heart failure; hypertrophic cardiomyopathy; structural heart disease; structural remodeling

Mesh:

Year:  2015        PMID: 26519209     DOI: 10.1111/jce.12872

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  3 in total

1.  Direct Current Cardioversion of Atrial Arrhythmias in Adults With Cardiac Amyloidosis.

Authors:  Edward A El-Am; Angela Dispenzieri; Rowlens M Melduni; Naser M Ammash; Roger D White; David O Hodge; Peter A Noseworthy; Grace Lin; Sorin V Pislaru; Alexander C Egbe; Martha Grogan; Vuyisile T Nkomo
Journal:  J Am Coll Cardiol       Date:  2019-02-12       Impact factor: 24.094

2.  Left ventricular remodeling in hypertrophic cardiomyopathy patients with atrial fibrillation.

Authors:  Hongwei Tian; Jingang Cui; Chengzhi Yang; Fenghuan Hu; Jiansong Yuan; Shengwen Liu; Weixian Yang; Xiaowei Jiang; Shubin Qiao
Journal:  BMC Cardiovasc Disord       Date:  2018-11-03       Impact factor: 2.298

3.  Anticoagulation with warfarin compared to novel oral anticoagulants for atrial fibrillation in adults with transthyretin cardiac amyloidosis: comparison of thromboembolic events and major bleeding.

Authors:  Lindsey R Mitrani; Jeffeny De Los Santos; Elissa Driggin; Rebecca Kogan; Stephen Helmke; Jeff Goldsmith; Angelo B Biviano; Mathew S Maurer
Journal:  Amyloid       Date:  2020-08-19       Impact factor: 7.141

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.